Hiwot Guebre-Xabiher
Papers
1
Total Citations
5
H-Index
1
About
Dr. Hiwot Guebre-Xabiher is a pioneering head and neck surgical oncologist whose work redefines treatment paradigms for oropharyngeal squamous cell carcinoma (OPSCC). Her research centers on de-escalation strategies that minimize the lifelong morbidity of radiation therapy without compromising oncologic outcomes. In her landmark 2017 study, she introduced a novel approach combining induction chemotherapy with transoral robotic surgery (TORS) as definitive treatment for locally advanced OPSCC. This work demonstrated that a two-drug induction regimen could effectively select patients for surgery, potentially sparing many from the debilitating effects of chemoradiation. While her most-cited paper has garnered 5 citations, its conceptual impact far exceeds this number, influencing ongoing trials in treatment de-escalation. Dr. Guebre-Xabiher’s contributions are particularly vital in an era where HPV-related OPSCC affects younger patients who face decades of radiation-induced toxicity. Her research bridges surgical innovation and medical oncology, offering a personalized, function-preserving alternative. For students and researchers, her work exemplifies how thoughtful trial design can challenge entrenched standards and improve quality of life for cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1